Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial

BACKGROUND: Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients. Several professional transplant societies and publications have generated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS Med
Asıl Yazarlar: Alloway, Rita R., Vinks, Alexander A., Fukuda, Tsuyoshi, Mizuno, Tomoyuki, King, Eileen C., Zou, Yuanshu, Jiang, Wenlei, Woodle, E. Steve, Tremblay, Simon, Klawitter, Jelena, Klawitter, Jost, Christians, Uwe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685573/
https://ncbi.nlm.nih.gov/pubmed/29135993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002428
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller